Multicenter, randomized, double-blind study comparing 10, 20 and 40 mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 42, Issue 4, 2006, Pages 384-391

  Tolia, Vasundhara ^a   Bishop, Phyllis R ^b   Tsou, V Marc ^c   Gremse, David ^d   Soffer, Elaine F ^e   Comer, Gail M ^e   Bishop, P ^b   Blumer, J ^f   Colletti, R ^g   Elitsur, Y ^h   Gremse, D ⁱ   Gunasekaran, T ^j   Gupta, S ^k   Hammo, A H ^l   Pohl, J F ^m   Tolia, V ^a   Tsou, V M ^c   Winter, H ⁿ  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OF THE KING S DAUGHTERS   (United States)

^d UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^e PFIZER INC   (United States)

^f CASE WESTERN RESERVE UNIVERSITY   (United States)

^g UNIVERSITY OF VERMONT   (United States)

^h University of Pediatrics   (United States)

ⁱ UNIVERSITY OF SOUTH ALABAMA   (United States)

^j Advocate Lutheran General Children's Hospital   (United States)

^k INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^l RHODE ISLAND HOSPITAL   (United States)

^m TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

ⁿ MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

GERD; Pediatrics; PPIs; Symptoms

Indexed keywords

ANTACID AGENT; CALCIUM CARBONATE; MYLANTA; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ABDOMINAL PAIN; ARTICLE; ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENTERIC COATED TABLET; FEMALE; GASTROESOPHAGEAL REFLUX; HEADACHE; HUMAN; INCREASED APPETITE; INFECTION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PHARYNGITIS; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SCORING SYSTEM; SYMPTOMATOLOGY; TREATMENT OUTCOME; URINE INCONTINENCE;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANTI-ULCER AGENTS; BENZIMIDAZOLES; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; OMEPRAZOLE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SULFOXIDES; TIME FACTORS; TREATMENT OUTCOME;

EID: 33744911969     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000214160.37574.d3     Document Type: Article

References (43)

1. Rudolph CD, Mazur LJ, Liptak GS, et al. Guidelines for evaluation and treatment of gastroesophageal reflux in infants and children: Recommendations of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 2001;32:S1-31.
2. Orenstein S. Tests to assess symptoms of gastroesophageal reflux in infants and children. J Pediatr Gastroenterol Nutr 2003;37:S29-32.
3. Badriul H, Vandenplas Y. Gastro-esophageal reflux in infancy. J Gastroenterol Hepatol 1999;14:13-9.
4. Gold BD. Outcomes of pediatric gastroesophageal reflux disease: In the first year of life, in childhood, and in adults...oh, and should we really leave Helicobacter pylori alone? J Pediatr Gastroenterol Nutr 2003;37:S33-9.
5. Gold BD. Review article: Epidemiology and management of gastro-esophageal reflux in children. Aliment Pharmacol Ther 2004;19(suppl 1):22-7.
6. Tolia V, Essenmacher L, Boyer K, et al. Gastroesophageal reflux disease impairs the quality of life in pediatric patients. J Pediatr Gastroenterol Nutr 2005.
7. Pace F, Sangaletti O, Trape E, et al. Short and long-term outcome of medically treated reflux esophagitis. Hepato-gastroenterology 1995;42:131-4.
8. Callahan CW. The diagnosis of gastroesophageal reflux in hospitalized infants. J Am Osteopath Assoc 1998;98:32-4.
9. Wetzel RC. Gastro-esophageal reflux: Theory over experience? Paediatr Anaesth 1998;8:101-4.
10. Nelson S, Chen E, Syniar G, et al. One-year follow-up of symptoms of gastroesophageal reflux during infancy. Pediatrics 1998;102:E67.
11. Tolia V, Boyer K. Long-term proton pump inhibitor use: safety in a cohort of 109 children. Gastroenterology 2005;128(suppl 2):M1069.
12. Liacouras CA, Markowitz JE. Eosinophilic esophagitis: A subset of eosinophilic gastroenteritis. Curr Gastroenterol Rept 1999;1:253-8.
13. Benjamin B, Pohl D, Bale PM. Endoscopy and biopsy in gastroesophageal reflux in infants and children. Ann Otol Rhinol Laryngol 1980;89:443-5.
14. Biller JA, Winter HS, Grand RJ, et al. Are endoscopic changes predictive of histologic esophagitis in children? J Pediatr 1983;103:215-8.
15. McVeigh K, Wetzel R. Issues in pediatric critical care medicine. Semin Anesth 1999;18:204-15.
16. Williams CN. Gastroesophageal reflux disease. Can J Gastroenterol 1998;12:107-8.
17. Khubchardavi S, Tolia V. Dietary management of gastroesophageal reflux - From infancy to adolescence. Curr Nutr Food Sci 2005;1:129-34.
18. Kromer W, Postius S, Riedel R, et al. BY 1023/SK&F 96022 INN pantoprazole, a novel gastric proton pump inhibitor, potently inhibits acid secretion but lacks relevant cytochrome P450 interactions. J Pharmacol Exp Ther 1990;254:129-35.
19. Andersson T. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole. Clin Pharmacokinet 1996;31:9-28.
20. Huber R, Kohl B, Sachs G, et al. Review article: The continuing development of proton pump inhibitors with particular reference to pantoprazole. Aliment Pharmacol Ther 1995;9:363-78.
21. Tucker GT. The interaction of proton pump inhibitors with cytochromes P450. Aliment Pharmacol Ther 1994;8:33-8.
22. Deal L, Gold BD, Gremse D, et al. Age-specific questionnaire distinguish GERD symptom frequency and severity in infants and young children; development and initial validation. J Pediatr Gastroenterol Nutr 2005;41:178-85.
23. Hetzel DJ, Dent J, Reed WD, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903-12.
24. Herbst JJ, Minton SD, Books LS. Gastroesophageal reflux causing respiratory distress and apnea in newborn infants. J Pediatr 1979;95:763-8.
25. Marino A, Assing E, Carbone M, et al. The incidence of gastroesophageal reflux in preterm infants. J Perinatol 1995;15:369-71.
26. Pashankar DS, Israel D. Gastric polyps and nodules in children receiving long-term omeprazole therapy. J Pediatr Gastroenterol Nutr 2002;35-658-62.
27. Israel D, Hassall E. Omeprazole and other proton pump inhibitors: Pharmacology, efficacy, and safety, with special reference to use in children. J Pediatr Gastroenterol Nutr 1998;27:568-79.
28. Gibbons TE, Gold BD. The use of proton pump inhibitors in children: a comprehensive review. Paediatr Drugs 2003;5:25-40.
29. Zimmerman AE, Walters JK, Katona BG, et al. A review of omeprazole use in the treatment of acid-related disorders in children. Clin Ther 2001;23:660-79.
30. Tolia V, Fitzgerald J, Hassall E, et al. Safety of lansoprazole in the treatment of GERD in children. J Pediatr Gastroenterol Nutr 2002;35:S300-7.
31. Ferron G, James LP, Kearns GL, et al. Pharmacokinetics of oral pantoprazole in pediatric patients. Pharmacotherapy 2002;22:1358.
32. Kearns GL, Ferron G, James LP, et al. Pantoprazole disposition in pediatrics. Clin Pharmacol Ther 2003;73:38.
33. Kearns GL, Andersson T, James LP, et al. Omeprazole disposition in children following single-dose administration. J Clin Pharmacol 2003;43:840-8.
34. Tran A, Rey E, Pons G, et al. Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children. Clin Pharmacol Ther 2002;71:359-67.
35. Kearns GL, Winter HS. Proton pump inhibitors in pediatrics: relevant pharmacokinetics and pharmacodynamics. J Pediatr Gastroenterol Nutr 2003;37:S52-9.
36. Litalien C, Theoret Y, Faure C. Pharmacokinetics of proton pump inhibitors in children. Clin Pharmacokinet 2005;44:441-66.
37. Madrazo-de la Garza A, Dibildox M, Vargas A, et al. Efficacy and safety of oral pantoprazole 20 mg given once daily for reflux esophagitis in children. J Pediatr Gastroenterol Nutr 2003;36:261-5.
38. Dammann HG. Pantoprazole in pediatric patients with peptic ulcer and reflex esophagitis. Med Klin 1998:7-9.
39. Alliet P, Raes M, Bruneel E, et al. Omeprazole in infants with cimetidine-resistant peptic esophagitis. J Pediatr 1998;132:353-4.
40. Stanghellini V. Management of gastroensophageal reflux disease. Drugs Today 2003;39:15-20.
41. Devalut K. Gastroesophageal reflux disease: Extraesophageal manifestations and therapy. Semin Gastroinfest Dis 2001;12:46-51.
42. DiPalma JA. Management of severe gastroesophageal reflux disease. J Clin Gastroenterology 2001;32:19-26.
43. Waldum HL, Brenna E, Sandvik AK. Long-term safety of proton pump inhibitors: risks of gastric neoplasia and infections. Expert Opin Drug Saf 2002;1:29-38.